Add-On Mavacamten Cuts Need for Septal Reduction in Obstructive HCM

(MedPage Today) -- WASHINGTON – Treatment with investigational mavacamten allowed patients with advanced obstructive hypertrophic cardiomyopathy (oHCM) to avoid septal reduction therapies (SRT), a researcher reported.
In the VALOR-HCM study...